Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
STIM | US
0.08
6.02%
Healthcare
Diagnostics & Research
30/06/2024
05/03/2026
1.41
1.36
1.46
1.35
Neuronetics Inc. a commercial stage medical technology company designs develops and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics Inc. was incorporated in 2001 and is headquartered in Malvern Pennsylvania.
View LessValue Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
73.6%1 month
133.0%3 months
116.4%6 months
101.2%-
-
1.52
3.23
0.65
-2.02
0.68
-
-24.65M
42.72M
42.72M
-
-51.71
-
-6.60
-100.13
1.57
1.98
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.28
Range1M
0.96
Range3M
1.14
Rel. volume
0.36
Price X volume
1.44M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Cytosorbents Corporation | CTSO | Diagnostics & Research | 0.8051 | 43.82M | 1.91% | n/a | 159.92% |
| Precipio Inc | PRPO | Diagnostics & Research | 26.52 | 39.31M | -1.16% | n/a | 9.66% |
| BioTelemetry Inc | BEAT | Diagnostics & Research | 1.4 | 37.19M | -8.50% | n/a | 0.00% |
| Biomerica Inc | BMRA | Diagnostics & Research | 1.97 | 33.14M | -2.96% | n/a | 13.22% |
| STAR EQUITY HOLDINGS INC | STRR | Diagnostics & Research | 10.05 | 32.38M | 1.21% | n/a | 26.85% |
| MYnd Analytics Inc | MYND | Diagnostics & Research | 0.4201 | 19.18M | -5.08% | n/a | 117.50% |
| VolitionRx Limited | VNRX | Diagnostics & Research | 0.1968 | 18.13M | -2.62% | n/a | -26.88% |
| Mainz Biomed B.V. Ordinary Shares | MYNZ | Diagnostics & Research | 0.8114 | 17.76M | -10.84% | n/a | 228.39% |
| bioAffinity Technologies Inc. | BIAF | Diagnostics & Research | 1.03 | 13.90M | 0.00% | n/a | 40.20% |
| INOTIV INC | NOTV | Diagnostics & Research | 0.332 | 8.63M | -7.50% | n/a | 236.01% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ILAG | ILAG | Building Products & Equipment | 2.32 | 41.90M | 0.87% | n/a | 5.48% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.29 | 33.46M | -2.04% | 0.03 | 16.03% |
| Reading International Inc | RDI | Media - Diversified | 1.03 | 29.08M | 0.98% | n/a | 4054.78% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.71 | 13.72M | 23.48% | n/a | 58.43% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.404 | 3.85M | -1.46% | n/a | 19.98% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.49 | 3.81M | -4.95% | n/a | 17.32% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.47 | 1.36M | 0.00% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0071 | 654.72K | 0.00% | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.02 | - | Cheaper |
| Ent. to Revenue | 0.68 | - | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 1.52 | 77.50 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 116.39 | - | Riskier |
| Debt to Equity | 3.23 | -14.36 | Expensive |
| Debt to Assets | 0.65 | 0.34 | Expensive |
| Market Cap | 42.72M | - | Emerging |